Vital Therapies,     
美国生命治疗公司是致力于研发肝脏疾病医疗新技术的高科技公司，目前已成功研制全球首例基于人源肝细胞的生物人工肝（ELAD®），产品在美国和中国均处于临床试验阶段。

Vital Therapies, Inc. is a biotherapeutic company developing a cell-based therapy targeting the treatment of acute liver failure. The company's lead product-candidate, ELAD, is an extracorporeal bio-artificial liver currently in phase 3 clinical trials. Vital Therapies, Inc. is based in San Diego, California.